Clinical trial

A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and Lymphoma

NCT07583771

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-06-01

PhasePHASE1

Study timeline

Study start (estimated)2026-06-01Date precision: month

Registry last updated2026-05-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pancreatic Adenocarcinomaunresolved

Non Small Cell Lung Cancerunresolved

Advanced Solid Tumorsunresolved

Lymphomaunresolved

Diffuse Large B-Cell Lymphoma (DLBCL)unresolved

Interventions

CS08399DRUG

Sponsors & collaborators

Chipscreen Biosciences, Ltd.lead sponsor

Mapped research locations

ShanghaiChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07583771 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.